February 17, 2023
We continue to care for COVID issues including longhaulers, or acute care of COVID vaccine injuries. We also address vaccine exemption care with a comprehensive evaluation. Fill out our form and we will reach out to you shortly.
September 1, 2021
The number of actively sick patients has significantly increased in August. We are no longer able to accept all who reach out to us regretfully. We will try to do our best. Fill out the COVID-19 form. The fee is $150.
December 14, 2020
I joined other America’s Frontline Doctors at the CDC in Atlanta. We are voicing our concerns about the experimental vaccine that is being distributed today. There are many factors that are concerning regarding the safety and efficacy of the vaccine. The vaccine has only been tested to determine if it lessens symptoms, not the transmission of the virus. It will do nothing to accomplish herd immunity.
September 21, 2020
We are offering hydroxychloroquine and curbside ozone therapy for COVID19 treatment and prevention if appropriate. Please call to schedule a Telemedicine consultation at 254.773.8339. As our commitment to the community, we are charging $125 for consultation and $5 a nominal fee just to cover our expenses for curbside nasal ozone.
July 30, 2020, Immediate Release Shelley G. Cole, MD
The State of Texas emergency revocation of the use of Hydroxychloroquine in prevention expired on July 17, 2020. If appropriate, following telemedicine evaluation, our office is currently taking calls in the state of Texas for care.
We are prioritizing those who are confirmed cases of COVID-19 who are unable to obtain medications.
July 28, 2020.
After months of uncertainty, we can now conclude from US data that the COVID-19 death rate is approximately .26%. That is extremely low! Lower than the 2019 or 2018 seasonal flu. Cases are up as more people are tested. As more people have immunity they are less likely to spread it to someone else.
Update: April 10, 2020
We are participating in an international study for the prevention of COVID19. We need your help! Go here to find out how you can be a part of the solution.
Receive the COVID-19 care you deserve.
Scientist from Stanford University School of Medicine, UAB School of Medicine and the National Academy of Sciences recently reported guidelines from South Korea and China that an antiviral medication can be used as an effective treatment against Coronavirus Disease 2019.
The US CDC and World Health Organization have not published treatment measures to date for COVID-19. Treatment guidelines using this medication are currently available in South Korea and China and reported to be “an effective treatment measures on human studies” for COVID-19.1
The antiviral medication is safe and effective and is listed on the WHO Model List of Essential Medicines (EML). The medication has been utilized for decades and used in all ages, as well as pregnant and nursing mothers. A prescription is necessary.
A Multi-Center Collaborative Group has established effective treatment measured based on human studies.2 “This research must be confirmed and furthermore ruled out that the subjects that had negative viral nucleic acid tests might not have been infected with C-19.”
According to South Korean and China human treatment guidelines, this medication can be implemented today in the U.S., Europe and the rest of the world. “The United States of America and other countries should immediately authorize and indemnify medical doctors for prescribing” this medication to treat COVID-19. This medication is not currently approved by the FDA for treatment or prevention of COVID-19.